OP009 Long-term safety and efficacy of golimumab in patients with moderately to severely active ulcerative colitis: Results from the PURSUIT-SC Maintenance study extensionWalter Reinisch, P. Rutgeerts, William J. Sandborn et al.|Journal of Crohn s and Colitis|2014Cited by 2